These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 26725257

  • 1. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG, Arnold R, Poynten AM, Howells J, Kiernan MC, Lin CS, Krishnan AV.
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [Abstract] [Full Text] [Related]

  • 2. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY, Tani J, Chang TS, Lin CS.
    PLoS One; 2017 Feb; 12(2):e0171223. PubMed ID: 28182728
    [Abstract] [Full Text] [Related]

  • 3. Decreased excitability of the distal motor nerve of young patients with type 1 diabetes mellitus.
    van der Heyden J, van der Meer P, Birnie E, de Coo IF, Castro Cabezas M, Ozcan B, Veeze H, Visser GH, Aanstoot HJ, Blok JH.
    Pediatr Diabetes; 2013 Nov; 14(7):519-25. PubMed ID: 23710907
    [Abstract] [Full Text] [Related]

  • 4. Sensory and motor axonal excitability testing in early diabetic neuropathy.
    Kristensen AG, Gylfadottir S, Itani M, Kuwabara S, Krøigård T, Khan KS, Finnerup NB, Andersen H, Jensen TS, Sindrup S, Tankisi H.
    Clin Neurophysiol; 2021 Jul; 132(7):1407-1415. PubMed ID: 34030050
    [Abstract] [Full Text] [Related]

  • 5. Correlation between markers of peripheral nerve function and structure in type 1 diabetes.
    Borire AA, Issar T, Kwai NC, Visser LH, Simon NG, Poynten AM, Kiernan MC, Krishnan AV.
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3028. PubMed ID: 29858541
    [Abstract] [Full Text] [Related]

  • 6. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
    Arnold R, Kwai N, Lin CS, Poynten AM, Kiernan MC, Krishnan AV.
    Diabetes Metab Res Rev; 2013 Jan; 29(1):53-9. PubMed ID: 23008000
    [Abstract] [Full Text] [Related]

  • 7. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV, Lin CS, Kiernan MC.
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [Abstract] [Full Text] [Related]

  • 8. Association of corneal nerve loss with markers of axonal ion channel dysfunction in type 1 diabetes.
    Tummanapalli SS, Issar T, Kwai N, Poynten A, Krishnan AV, Willcox M, Markoulli M.
    Clin Neurophysiol; 2020 Jan; 131(1):145-154. PubMed ID: 31765978
    [Abstract] [Full Text] [Related]

  • 9. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.
    Sima AA, Nathaniel V, Bril V, McEwen TA, Greene DA.
    J Clin Invest; 1988 Feb; 81(2):349-64. PubMed ID: 3339124
    [Abstract] [Full Text] [Related]

  • 10. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY, Park SB, Liu YT, Kwai N, Arnold R, Krishnan AV, Lin CS.
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [Abstract] [Full Text] [Related]

  • 11. Altered nerve excitability properties in established diabetic neuropathy.
    Krishnan AV, Kiernan MC.
    Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
    [Abstract] [Full Text] [Related]

  • 12. Altered peripheral nerve structure and function in latent autoimmune diabetes in adults.
    Issar T, Yan A, Kwai NCG, Poynten AM, Borire AA, Arnold R, Krishnan AV.
    Diabetes Metab Res Rev; 2020 Mar; 36(3):e3260. PubMed ID: 31833206
    [Abstract] [Full Text] [Related]

  • 13. Nodal Na(+)-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: prevention by aldose reductase inhibition.
    Cherian PV, Kamijo M, Angelides KJ, Sima AA.
    J Diabetes Complications; 1996 Mar; 10(4):192-200. PubMed ID: 8835918
    [Abstract] [Full Text] [Related]

  • 14. Tibial nerve axonal excitability in type 1 diabetes mellitus.
    Gencpinar P, Çelmeli G, Duman Ö, Haspolat Ş, Uysal H.
    Muscle Nerve; 2019 Jan; 59(1):76-81. PubMed ID: 30019351
    [Abstract] [Full Text] [Related]

  • 15. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.
    Sima AA, Lattimer SA, Yagihashi S, Greene DA.
    J Clin Invest; 1986 Feb; 77(2):474-84. PubMed ID: 3003160
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Axonal potassium conductance and glycemic control in human diabetic nerves.
    Misawa S, Kuwabara S, Kanai K, Tamura N, Hiraga A, Nakata M, Ogawara K, Hattori T.
    Clin Neurophysiol; 2005 May; 116(5):1181-7. PubMed ID: 15826860
    [Abstract] [Full Text] [Related]

  • 18. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N, Arnold R, Poynten AM, Lin CS, Kiernan MC, Krishnan AV.
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [Abstract] [Full Text] [Related]

  • 19. Evolution of peripheral nerve function in humans: novel insights from motor nerve excitability.
    Farrar MA, Park SB, Lin CS, Kiernan MC.
    J Physiol; 2013 Jan 01; 591(1):273-86. PubMed ID: 23006483
    [Abstract] [Full Text] [Related]

  • 20. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
    Park SB, Lin CS, Krishnan AV, Goldstein D, Friedlander ML, Kiernan MC.
    Brain; 2009 Oct 01; 132(Pt 10):2712-23. PubMed ID: 19745023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.